Anti-GPR55 monoclonal antibody
Pre-made anti-GPR55 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to GPR55/GPR55 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0028-Ab-1/ GM-Tg-hg-IP0028-Ab-2 | Anti-Human GPR55 monoclonal antibody | Human |
GM-Tg-rg-IP0028-Ab-1/ GM-Tg-rg-IP0028-Ab-2 | Anti-Rat GPR55 monoclonal antibody | Rat |
GM-Tg-mg-IP0028-Ab-1/ GM-Tg-mg-IP0028-Ab-2 | Anti-Mouse GPR55 monoclonal antibody | Mouse |
GM-Tg-cynog-IP0028-Ab-1/ GM-Tg-cynog-IP0028-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GPR55 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0028-Ab-1/ GM-Tg-felg-IP0028-Ab-2 | Anti-Feline GPR55 monoclonal antibody | Feline |
GM-Tg-cang-IP0028-Ab-1/ GM-Tg-cang-IP0028-Ab-2 | Anti-Canine GPR55 monoclonal antibody | Canine |
GM-Tg-bovg-IP0028-Ab-1/ GM-Tg-bovg-IP0028-Ab-2 | Anti-Bovine GPR55 monoclonal antibody | Bovine |
GM-Tg-equg-IP0028-Ab-1/ GM-Tg-equg-IP0028-Ab-2 | Anti-Equine GPR55 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0028-Ab-1/ GM-Tg-hg-IP0028-Ab-2; GM-Tg-rg-IP0028-Ab-1/ GM-Tg-rg-IP0028-Ab-2; GM-Tg-mg-IP0028-Ab-1/ GM-Tg-mg-IP0028-Ab-2; GM-Tg-cynog-IP0028-Ab-1/ GM-Tg-cynog-IP0028-Ab-2; GM-Tg-felg-IP0028-Ab-1/ GM-Tg-felg-IP0028-Ab-2; GM-Tg-cang-IP0028-Ab-1/ GM-Tg-cang-IP0028-Ab-2; GM-Tg-bovg-IP0028-Ab-1/ GM-Tg-bovg-IP0028-Ab-2; GM-Tg-equg-IP0028-Ab-1/ GM-Tg-equg-IP0028-Ab-2 |
Products Name | Anti-GPR55 monoclonal antibody |
Format | mab |
Target Name | GPR55 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-GPR55 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0028-Ag-1 | Recombinant multi-species GPR55/ LPIR1 protein |
ORF Viral Vector | vGMLP000400 | human GPR55 Lentivirus particle |
ORF Viral Vector | pGMLP000400 | human GPR55 Lentivirus plasmid |
ORF Viral Vector | pGMLPm001267 | mouse Gpr55 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001267 | mouse Gpr55 Lentivirus particle |
Target information
Target ID | GM-IP0028 |
Target Name | GPR55 |
Gene ID | 9290,227326,501177,711323,486157,101094199,539107,100063969 |
Gene Symbol and Synonyms | CTFL,Gm218,GPR55,LPIR1 |
Uniprot Accession | Q9Y2T6 |
Uniprot Entry Name | GPR55_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target |
Disease | N/A |
Gene Ensembl | ENSG00000135898 |
Target Classification | N/A |
The target: GPR55, gene name: GPR55, also named as LPIR1. This gene belongs to the G-protein-coupled receptor superfamily. The encoded integral membrane protein is a likely cannabinoid receptor. It may be involved in several physiological and pathological processes by activating a variety of signal transduction pathways. [provided by RefSeq, Aug 2013].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.